×
Health Catalyst EBITDA 2018-2025 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Health Catalyst ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Health Catalyst EBITDA 2018-2025 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Health Catalyst ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$44B
Tempus AI (TEM)
$13.2B
Doximity (DOCS)
$12.7B
Hims & Hers Health (HIMS)
$9.6B
IRhythm Technologies (IRTC)
$5.5B
Hinge Health (HNGE)
$4.4B
Privia Health (PRVA)
$2.8B
Inspire Medical Systems (INSP)
$2.8B
Heartflow (HTFL)
$2.6B
Phreesia (PHR)
$1.9B
Enovis (ENOV)
$1.8B
10x Genomics (TXG)
$1.7B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.4B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.3B
Claritev (CTEV)
$1.1B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$679M
Zepp Health (ZEPP)
$652M
Veradigm (MDRX)
$531M
Standard BioTools (LAB)
$481M
Talkspace (TALK)
$445M
Butterfly Network (BFLY)
$405M
Carlsmed (CARL)
$353M
TruBridge (TBRG)
$300M
Outset Medical (OM)
$247M
SOPHiA GENETICS SA (SOPH)
$234M
Nyxoah SA (NYXH)
$213M
KORU Medical Systems (KRMD)
$195M